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Abstract
Isolation and separation of specific molecules is used in almost all areas of biosciences and
biotechnology. Diverse procedures can be used to achieve this goal. Recently, increased attention
has been paid to the development and application of magnetic separation techniques, which employ
small magnetic particles. The purpose of this review paper is to summarize various methodologies,
strategies and materials which can be used for the isolation and purification of target proteins and
peptides with the help of magnetic field. An extensive list of realised purification procedures
documents the efficiency of magnetic separation techniques.
Introduction
Isolation, separation and purification of various types of
proteins and peptides, as well as of other specific mole-
cules, is used in almost all branches of biosciences and
biotechnologies. Separation science and technology is
thus very important area necessary for further develop-
ments in bio-oriented research and technology. New sep-
aration techniques, capable of treating dilute solutions or
solutions containing only minute amounts of target mol-
ecules in the presence of vast amounts of accompanying
compounds in both small and large-scale processes, even
in the presence of particulate matter, are necessary.
In the area of biosciences and biotechnology the isolation
of proteins and peptides is usually performed using vari-
ety of chromatography, electrophoretic, ultrafiltration,
precipitation and other procedures, affinity chromatogra-
phy being one of the most important techniques. Affinity
ligand techniques represent currently the most powerful
tool available to the downstream processing both in term
of their selectivity and recovery. The strength of column
affinity chromatography has been shown in thousands of
successful applications, especially in the laboratory scale.
However, the disadvantage of all standard column liquid
chromatography procedures is the impossibility of the
standard column systems to cope with the samples con-
taining particulate material so they are not suitable for
work in early stages of the isolation/purification process
where suspended solid and fouling components are
present in the sample. In this case magnetic affinity, ion-
exchange, hydrophobic or adsorption batch separation
processes, applications of magnetically stabilized fluid-
ized beds or magnetically modified two-phase systems
have shown their usefulness.
The basic principle of batch magnetic separation is very
simple. Magnetic carriers bearing an immobilized affinity
or hydrophobic ligand or ion-exchange groups, or mag-
netic biopolymer particles having affinity to the isolated
structure, are mixed with a sample containing target
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compound(s). Samples may be crude cell lysates, whole
blood, plasma, ascites fluid, milk, whey, urine, cultivation
media, wastes from food and fermentation industry and
many others. Following an incubation period when the
target compound(s) bind to the magnetic particles the
whole magnetic complex is easily and rapidly removed
from the sample using an appropriate magnetic separator.
After washing out the contaminants, the isolated target
compound(s) can be eluted and used for further work.
Magnetic separation techniques have several advantages
in comparison with standard separation procedures. This
process is usually very simple, with only a few handling
steps. All the steps of the purification procedure can take
place in one single test tube or another vessel. There is no
need for expensive liquid chromatography systems, cen-
trifuges, filters or other equipment. The separation process
can be performed directly in crude samples containing
suspended solid material. In some cases (e.g., isolation of
intracellular proteins) it is even possible to integrate the
disintegration and separation steps and thus shorten the
total separation time [1]. Due to the magnetic properties
of magnetic adsorbents (and diamagnetic properties of
majority of the contaminating molecules and particles
present in the treated sample), they can be relatively easily
and selectively removed from the sample. In fact, mag-
netic separation is the only feasible method for recovery
of small magnetic particles (diameter ca 0.1 – 1 µm) in the
presence of biological debris and other fouling material of
similar size. Moreover, the power and efficiency of mag-
netic separation procedures is especially useful at large-
scale operations. The magnetic separation techniques are
also the basis of various automated procedures, especially
magnetic-particle based immunoassay systems for the
determination of a variety of analytes, among them pro-
teins and peptides. Several automated systems for the sep-
aration of proteins or nucleic acids have become available
recently.
Magnetic separation is usually very gentle to the target
proteins or peptides. Even large protein complexes that
tend to be broken up by traditional column chromatogra-
phy techniques may remain intact when using the very
gentle magnetic separation procedure [2]. Both the
reduced shearing forces and the higher protein concentra-
tion throughout the isolation process positively influence
the separation process.
Separation of target proteins using standard chromatogra-
phy techniques often leads to the large volume of diluted
protein solution. In this case appropriate magnetic parti-
cles can be used for their concentration instead of ultrafil-
tration, precipitation etc. [3].
The purpose of this review is to summarize various meth-
odologies and strategies which can be employed for the
isolation and purification of target proteins and peptides
with the help of magnetic materials. An extensive list of
realised purification procedures documents the efficiency
of magnetic separation techniques. All these information
will help the scientists to select the optimal magnetic
material and the purification procedure.
Necessary materials and equipment
The basic equipment for laboratory experiments is very
simple. Magnetic carriers with immobilized affinity or
hydrophobic ligands, magnetic particles prepared from a
biopolymer exhibiting affinity for the target compound(s)
or magnetic ion-exchangers are usually used to perform
the isolation procedure. Magnetic separators of different
types can be used for magnetic separations, but many
times cheap strong permanent magnets are equally effi-
cient, especially in preliminary experiments.
Magnetic carriers and adsorbents can be either prepared
in the laboratory, or commercially available ones can be
used. Such carriers are usually available in the form of
magnetic particles prepared from various synthetic poly-
mers, biopolymers or porous glass, or magnetic particles
based on the inorganic magnetic materials such as surface
modified magnetite can be used. Many of the particles
behave like superparamagnetic ones responding to an
external magnetic field, but not interacting themselves in
the absence of magnetic field. This is important due to the
fact that magnetic particles can be easily resuspended and
remain in suspension for a long time. In most cases, the
diameter of the particles differs from ca 50 nm to approx.
10 µm. However, also larger magnetic affinity particles,
with the diameters up to millimetre range, have been suc-
cessfully used [4]. Magnetic particles having the diameter
larger than ca 1 µm can be easily separated using simple
magnetic separators, while separation of smaller particles
(magnetic colloids with the particle size ranging between
tens and hundreds of nanometers) may require the usage
of high gradient magnetic separators.
Commercially available magnetic particles can be
obtained from a variety of companies. In most cases pol-
ystyrene is used as a polymer matrix, but carriers based on
cellulose, agarose, silica, porous glass or silanized mag-
netic particles are also available. Examples of magnetic
particles used (or usable) for proteins and peptides sepa-
ration can be found elsewhere [5-7].
Particles with immobilised affinity ligands are available
for magnetic affinity adsorption. Streptavidin, antibodies,
protein A and Protein G are used most often in the course
of protein and peptides isolation. Magnetic particles with
above mentioned immobilised ligands can also serve asBioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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generic solid phases to which native or modified affinity
ligands can be immobilised (e.g., antibodies in the case of
immobilised protein A, protein G or secondary antibod-
ies, biotinylated molecules in the case of immobilised
streptavidin).
Also some other affinity ligands (e.g., nitrilotriacetic acid,
glutathione, trypsin, trypsin inhibitor, gelatine etc.) are
already immobilised to commercially available carriers.
To immobilise other ligands of interest to both commer-
cial and laboratory made magnetic particles standard pro-
cedures used in affinity chromatography can be
employed. Usually functional groups available on the sur-
face of magnetic particles such as -COOH, -OH or -NH2
are used for immobilisation, in some cases magnetic par-
ticles are available already in the activated form (e.g., tosy-
lactivated, epoxyactivated etc).
In the laboratory magnetite (or similar magnetic materials
such as maghemite or ferrites) particles can be surface
modified by silanization. This process modifies the sur-
face of the inorganic particles so that appropriate func-
tional groups become available, which enable easy
immobilisation of affinity ligands [8]. In exceptional cases
enzyme activity can be decreased as a result of usage of
magnetic particles with exposed iron oxides. In this case
encapsulated microspheres, having an outer layer of pure
polymer, will be safer.
Biopolymers such as agarose, chitosan, kappa carrageenan
and alginate can be easily prepared in a magnetic form. In
the simplest way the biopolymer solution is mixed with
magnetic particles and after bulk gel formation the mag-
netic gel formed is mechanically broken into fine particles
[9]. Alternatively biopolymer solution containing dis-
persed magnetite is dropped into a mixed hardening solu-
tion [4] or water-in-oil suspension technique is used to
prepare spherical particles [10].
Basically the same procedures can be used to prepare mag-
netic particles from synthetic polymers such as polyacryla-
mide, poly(vinylalcohol) and many others [11].
In another approach used standard affinity or ion-
exchange chromatography material was post-magnetised
by interaction of the sorbent with water-based ferrofluid.
Magnetic particles accumulated within the pores of chro-
matography adsorbent thus modifying this material into
magnetic form [12,13]. Alternatively magnetic Sepharose
or other agarose gels were prepared by simple contact with
freshly precipitated or finely powdered magnetite [12,14].
Magnetoliposomes (magnetic derivatives of standard
liposomes), either in the original form or after immobili-
zation of specific proteins, have the potential for the sep-
aration of antiphospholipid antibodies [15], IgG
antibodies [16] and other proteins of interest [17].
Recently also non-spherical magnetic structures, such as
magnetic nanorods have been tested as possible adsorb-
ent material for specific separation of target proteins [18].
Magnetic separators are necessary to separate the mag-
netic particles from the system. In the simplest approach,
a small permanent magnet can be used, but various mag-
netic separators employing strong rare-earth magnets can
be obtained at reasonable prices. Commercial laboratory
scale batch magnetic separators are usually made from
magnets embedded in disinfectant-proof material. The
racks are constructed for separations in Eppendorf micro-
tubes, standard test tubes or centrifugation cuvettes, some
of them have a removable magnetic plate to facilitate easy
washing of separated magnetic particles. Other types of
separators enable separations from the wells of microtitra-
tion plates and the flat magnetic separators are useful for
separation from larger volumes of suspensions (up to
approx. 500 – 1000 ml). Examples of typical batch mag-
netic separators are shown in Fig. 1.
Flow-through magnetic separators are usually more
expensive, and high gradient magnetic separators
(HGMS) are the typical examples. Laboratory scale HGMS
is composed from a column packed with fine magnetic
grade stainless steel wool or small steel balls which is
placed between the poles of an appropriate magnet. The
suspension is pumped through the column, and magnetic
particles are retained within the matrix. After removal the
column from the magnetic field, the particles are retrieved
by flow and usually by gentle vibration of the column.
For work in dense suspensions, open gradient magnetic
separators may be useful. A very simple experimental set-
up for the separation of magnetic affinity adsorbents from
litre volumes of suspensions was described [19].
Currently many projects require the analysis of a high
number of individual proteins or variants. Therefore,
methods are required that allows multiparallel processing
of different proteins. There are several multiple systems
for high throughput nucleic acid and proteins preparation
commercially available. The most often used approach for
proteins isolation is based on the isolation and assay of
6xHis-tagged recombinant proteins using magnetic beads
with Ni-nitriloacetic acid ligand [20]. The commercially
available platforms can be obtained from several compa-
nies such as Qiagen, USA (BioRobot and BioSprint series),
Tecan, Japan (Te-MagS) or Thermo Electron Corporation,
USA (KingFisher).BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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Examples of batch magnetic separators applicable for magnetic separation of proteins and peptides Figure 1
Examples of batch magnetic separators applicable for magnetic separation of proteins and peptides. A: Dynal MPC -S for six 
microtubes (Dynal, Norway); B: Dynal MPC – 1 for one test tube (Dynal, Norway); C: Dynal MPC – L for six test tubes (Dynal, 
Norway); D: magnetic separator for six Eppendorf tubes (New England BioLabs, USA); E: MagneSphere Technology Magnetic 
Separation Stand, two position (Promega, USA); F: MagnaBot Large Volume Magnetic Separation Device (Promega, USA); G: 
MagneSphere Technology Magnetic Separation Stand, twelve-position (Promega, USA); H: Dynal MPC – 96 S for 96-well 
microtitre plates (Dynal, Norway); I: MagnaBot 96 Magnetic Separation Device for 96-well microtitre plates (Promega, USA); J: 
BioMag Solo-Sep Microcentrifuge Tube Separator (Polysciences, USA); K: BioMag Flask Separator (Polysciences, USA); L: Mag-
neSil Magnetic Separation Unit (Promega, USA); M: MCB 1200 processing system for 12 microtubes based on MixSep process 
(Sigris Research, USA); N: PickPen magnetic tool (Bio-Nobile, Finland). Reproduced with the permission of the above men-
tioned companies; the photos were taken from their www pages.
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Basic principles of magnetic separations of 
proteins and peptides
Magnetic separations of proteins and peptides are usually
convenient and rapid. Nevertheless, several hints may be
helpful to obtain good results.
Proteins and peptides in the free form can be directly iso-
lated from different sources. Membrane bound proteins
have to be usually solubilized using appropriate deter-
gents. When nuclei are broken during sample preparation,
DNA released into the lysate make the sample very vis-
cous. This DNA may be sheared by repeated passage up
and down through a 21 gauge hypodermic syringe needle
before isolation of a target protein. Alternatively, DNase
can be added to enzymatically digest the DNA.
Magnetic beads in many cases exhibit low non-specific
binding of non-target molecules present in different sam-
ples. Certain samples may still require preclearing to
remove molecules which have high non-specific binding
activity. If preclearing is needed, the sample can be mixed
with magnetic beads not coated with the affinity ligand. In
the case of immunomagnetic separation, magnetic beads
coated with secondary antibody or with irrelevant anti-
bodies have been used. The non-specific binding can also
be minimised by adding a non-ionic detergent both in the
sample and in the washing buffers after isolation of the
target.
In general, magnetic affinity separations can be performed
in two different modes. In the direct method, an appropri-
ate affinity ligand is directly coupled to the magnetic par-
ticles or biopolymer exhibiting the affinity towards target
compound(s) is used in the course of preparation of mag-
netic affinity particles. These particles are added to the
sample and target compounds then bind to them. In the
indirect method the free affinity ligand (in most cases an
appropriate antibody) is added to the solution or suspen-
sion to enable the interaction with the target compound.
The resulting complex is then captured by appropriate
magnetic particles. In case antibodies are used as free
affinity ligands, magnetic particles with immobilised sec-
ondary antibodies, protein A or protein G are used for
capturing of the complex. Alternatively the free affinity
ligands can be biotinylated and magnetic particles with
immobilised streptavidin or avidin are used to capture the
complexes formed. In both methods, magnetic particles
with isolated target compound(s) are magnetically sepa-
rated and then a series of washing steps is performed to
remove majority of contaminating compounds and parti-
cles. The target compounds are then usually eluted, but for
specific applications (especially in molecular biology,
bioanalytical chemistry or environmental chemistry) they
can be used still attached to the particles, such as in the
case of polymerase chain reaction, magnetic ELISA etc.
The two methods perform equally well, but, in general,
the direct technique is more controllable. The indirect
procedure may perform better if affinity ligands have poor
affinity for the target compound.
In most cases, magnetic batch adsorption is used to per-
form the separation step. This approach represents the
simplest procedure available, enabling to perform the
whole separation in one test-tube or flask. If larger mag-
netic particles (with diameters above ca 1 µm) are used,
simple magnetic separators can be employed. In case mag-
netic colloids (diameters ranging between tens and hun-
dreds of nanometres) are used as affinity adsorbents,
high-gradient magnetic separators have usually to be used
to remove the magnetic particles from the system.
Alternatively magnetically stabilised fluidised beds
(MSFB), which enable a continuous separation process,
can be used. The use of MSFB is an alternative to conven-
tional column operation, such as packed-bed or fluidised
bed, especially for large-scale purification of biological
products. Magnetic stabilisation enables the expansion of
a packed bed without mixing of solid particles. High col-
umn efficiency, low pressure drop and elimination of
clogging can be reached [21,22].
Also non-magnetic chromatographic adsorbents can be
stabilized in magnetically stabilized fluidized beds if suf-
ficient amount of magnetically susceptible particles is also
present. The minimum amount of magnetic particles nec-
essary to stabilize the bed is a function of various param-
eters including the size and density of both particles, the
magnetic field strength, and the fluidization velocity. A
variety of commercially available affinity, ion-exchange,
and adsorptive supports can be used in the bed for contin-
uous separations [23].
Biocompatible two phase systems, composed for example
from dextran and polyethylene glycol, are often used for
isolation of biologically active compounds, subcellular
organelles and cells. One of the disadvantages of this sys-
tem is the slow separation of the phases when large
amounts of proteins and cellular components are present.
The separation of the phases can be accelerated by the
addition of fine magnetic particles or ferrofluids to the
system followed by the application of a magnetic field.
This method seems to be useful when the two phases have
very similar densities, the volumetric ratio between the
phases is very high or low, or the systems are viscous. Mag-
netically enhanced phase separation usually increases the
speed of phase separation by a factor of about 10 in well-
behaved systems, but it may increase by a factor of many
thousands in difficult systems. The addition of ferrofluids
and/or iron oxide particles was shown to have usually noBioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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influence on enzyme partioning or enzyme activity
[24,25].
Proteins and peptides isolated using magnetic techniques
have to be usually eluted from the magnetic separation
materials. In most cases bound proteins and peptides can
be submitted to standard elution methods such as the
change of pH, change of ionic strength, use of polarity
reducing agents (e.g., dioxane or ethyleneglycol) or the
use of deforming eluents containing chaotropic salts.
Affinity elution (e.g., elution of glycoproteins from lectin
coated magnetic beads by the addition of free sugar) may
be both a very efficient and gentle procedure.
Examples of magnetic separations of proteins 
and peptides
Magnetic affinity and ion-exchange separations have been
successfully used in various areas, such as molecular biol-
ogy, biochemistry, immunochemistry, enzymology, ana-
lytical chemistry, environmental chemistry etc [26-29].
Tables 1, 2, 3, 4, 5, 6, 7, 8, 9 show some selected applica-
tions of these techniques for proteins and peptides
isolation.
In the case of proteins and peptides purifications, no sim-
ple strategy for magnetic affinity separations exists. Vari-
ous affinity ligands have been immobilised on magnetic
particles, or magnetic particles have been prepared from
biopolymers exhibiting the affinity for target enzymes or
lectins. Immunomagnetic particles, i.e. magnetic particles
with immobilised specific antibodies against the target
Table 1: Examples of proteinases and peptidases purified by magnetic techniques
Purified enzyme Source Magnetic carrier Affinity ligand Further details Reference
Aminopeptidase Arabidopsis Amine-terminated magnetic 
beads
N-1-Naphthylphthalamic 
acid
KCl gradient elution [54]
Angiotensin-
converting enzyme
Pig lung membranes Dynabeads Polyclonal antibodies [57]
Bromelain Commercial 
preparation
Polyacrylic acid – iron oxide 
magnetic nanoparticles
Elution with KCl solution [59]
Caspase 
(recombinant, 
histidine-tailed)
Human cells Magnetic agarose Ni-NTA Elution with SDS-PAGE 
buffer
[60]
Chymotrypsin Commercial 
preparation
Magnetic chitosan beads Elution with N-acetyl-D-
tryptophan
[62]
NIa-protease 
(recombinant, 
histidine-tagged)
Plum Pox Virus Magnetic core and nickel-
silica composite matrix
Ni2+ Elution with imidazole 
containing buffer
[36]
Proteinases Commercial 
sources
Magnetic cross-linked 
erythrocytes
Elution with low pH 
buffer
[46]
Proteinase, bacterial 
(Savinase)
Bacillus clausii Silanized magnetite particles Bacitracin [84]
Trypsin Porcine pancreatin Silanized magnetite particles p-Aminobenzamidine Elution with low pH 
buffer
[50]
Porcine pancreatin Magnetic polymer particles Soybean trypsin inhibitor Elution with low pH 
solution
[86]
Commercial 
preparation
Silanized ferrite powder Soybean trypsin inhibitor [87]
Commercial 
preparation
Magnetic κ-carrageenan 
particles
Soybean trypsin inhibitor Elution with low pH 
solution, MSFB
[88][89]
Commercial 
preparation
Magnetic polyacrylamide 
beads
Soybean trypsin inhibitor Magnetically stabilized 
fluidized beds
[90]
Commercial 
preparation
Magnetic chitosan particles Aprotinin Elution with low pH 
solution
[91]
Commercial 
preparation
Magnetic cross-linked 
erythrocytes
Elution with low pH 
buffer; separation from 
large volume sample
[19]
Urokinase Crude urokinase 
preparation
Magnetic dextran, agarose, 
polyvinyl alcohol, 
polyhydroxyethyl 
methacrylate microspheres
p-Aminobenzamide, L-
arginine methyl ester, 
guanidine hexanoic acid or 
guanidine acetic acid
[93]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
Page 7 of 17
(page number not for citation purposes)
Table 2: Purification of lysozyme by magnetic techniques
Purified enzyme Source Magnetic carrier Affinity ligand Further details Reference
Lysozyme Hen egg white Magnetic chitin Elution with 0.01 M 
HCl
[71]
Hen egg white Magnetic acetylated chitosan Elution with 0.01 M 
HCl
[9]
Commercial 
preparation
Magnetic poly(2-
hydroxyethyl methacrylate)
Cibacron Blue F3GA Elution with 1 M 
KSCN
[72]
Magnetic chitosan beads Magnetically stabilized 
fluidized bed
[73]
Ornithodoros moubata Magnetic chitin Elution with alkaline, 
high salt buffer
[74]
Commercial 
preparation
Magnetic cross-linked 
polyvinylalcohol
Cibacron blue 3GA Elution with high salt 
buffer
[52]
Magnetite – polyacrylic acid 
nanoparticles
Ion-exchange 
separation
[75]
Magnetic cross-linked 
polyvinylalcohol beads
Adsorption study [76]
Commercial 
preparation
Magnetic agarose beads Cibacron blue 3GA Magnetically stabilized 
fluidized bed
[77]
Magnetic chitosan Cibacron blue 3GA Study of adsorption 
properties
[78]
Commercial 
preparation
Ferrofluid modified sawdust Elution with 0.5 M 
NaCl
[79]
Commercial 
preparation
Nano-sized magnetic 
particles
Elution with NaH2PO4 
and NaSCN
[80]
Lysozyme (recombinant, 
histidine-tailed)
T4 BioMag, amine terminated Iminodiacetic acid 
charged with Cu2+
Elution with low pH 
buffer
[81]
Table 3: Examples of polysaccharide and disaccharide hydrolases purified by magnetic techniques
Purified enzyme Source Magnetic carrier Affinity ligand Further details Reference
α-Amylases Porcine pancreas, 
Bacillus subtilis, wheat 
germ
Magnetic alginate 
beads
Elution with 1 M 
maltose
[4]
Bacillus 
amyloliquefaciens, 
porcine pancreas
Magnetic alginate 
microbeads
Elution with 1 M 
maltose
[10]
β-Amylase Sweet potato Magnetic alginate 
beads
Elution with 1 M 
maltose
[55]
β-Galactosidase Escherichia coli 
homogenate
Silanized magnetite p-Aminophenyl-β-D-
thiogalactopyranoside
Elution with borate 
buffer, pH 10
[58]
β-Galactosidase (fusion 
protein comprising the 
DNA-binding lac 
repressor)
Bacterial lysate Magnetic beads DNA containing Escherichia 
coli lac operator
Elution with lactose 
analogue
[64]
Glucoamylase Aspergillus niger Magnetic alginate 
beads
Elution with 1 M 
maltose
[55]
Pectinase Commercial 
preparation
Magnetic alginate 
beads
[82]
Pullulanase Bacillus acidopullulyticus Magnetic alginate 
beads
Elution with 1 M 
maltose
[55]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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Table 4: Examples of other enzymes purified by magnetic techniques
Purified enzyme Source Magnetic carrier Affinity ligand Further details Reference
Alcohol 
dehydrogenase
Yeast homogenate Magnetic cross-linked 
polyvinylalcohol
Cibacron blue 3GA Elution with high salt 
buffer
[52]
Saccharomyces 
cerevisiae extract
PEG with bound 
Cibacron blue
Magnetic two-phase 
system
[53]
Aldolase 
(recombinant, 
histidine tagged)
Pea Magnetic core and 
nickel-silica composite 
matrix
Ni2+ Elution with imidazole 
containing buffer
[36]
AngioI-TEM-β-
lactamase
Escherichia coli cells 
extracts
Magnetic agarose 
beads
Iminodiacetic acid 
charged with Zn2+
Elution with low pH 
buffer
[56]
Asparaginase Escherichia coli 
homogenate
Magnetic 
polyacrylamide gel 
particles
D-Asparagine Elution with D-
asparagine solution
[58]
Carbonic anhydrase Model mixture Magnetic agarose 
beads
Sulfanilimide Elution with high salt 
buffer
[14]
Catalase Bovine liver, 
commercial 
preparation
Magnetic 
poly(EGDMA-MAH) 
beads
Fe3+ Elution with NaSCN 
solution
[61]
Cytochrome c Horse, Candida krusei Amine terminated 
iron oxide particles
Iminodiacetic acid 
charged with Cu2+
Binding studies [63]
Commercial 
preparation
Au@magnetic 
particles
MALDI MS analysis [31]
Horse heart Magnetic agarose 
beads
Iminodiacetic acid 
charged with Cu2+
Elution with EDTA 
containing buffer
[56]
Bovine heart Magnetic ion-
exchange particles
Protein binding 
studies
[12]
Glucose-6-phosphate 
dehydrogenase
Ferrofluid modified 
Sepharose 4B
ADP [65]
Saccharomyces 
cerevisiae extract
PEG with bound 
Cibacron blue
Magnetic two-phase 
system
[53]
Hexokinase Escherichia coli 
homogenate
PEG with bound 
Cibacron blue
Magnetic two-phase 
system
[53]
Lactate 
dehydrogenase
Beef heart Ferrofluid modified 
Sepharose 4B
AMP Elution with 1 mM 
NADH
[13]
Porcine muscle Magnetic agarose 
beads
Reactive Red 120 Column elution with 
NaCl gradient
[66]
Lactoperoxidase Sweet whey Magnetic cation 
exchanger
HGMS [67,68]
Luciferase (histidine-
tagged)
Escherichia coli 
homogenate
MagneHis™ system Ni2+ [69,70]
Phosphatase, alkaline Human placenta Dynabeads M-450 Specific antibody Activity of bound 
enzyme measured
[83]
Phosphatase, alkaline 
(fusion protein 
comprising the DNA-
binding lac repressor)
Bacterial lysate Magnetic beads DNA containing 
Escherichia coli lac 
operator
Elution with lactose 
analogue
[64]
Phosphofructokinase Saccharomyces 
cerevisiae extract
PEG with bound 
Cibacron blue
Magnetic two-phase 
system
[53]
6-Phosphogluconate 
dehydrogenase
Ferrofluid modified 
Sepharose 4B
ADP Elution with 1 mM 
NADP
[13]
Thioredoxin 
(recombinant, 
histidine-tagged)
Escherichia coli Magnetic agarose Ni-NTA Elution with imidazole 
containing buffer
[20]
tRNA methionyl 
synthetase 
(recombinant, 
histidine-tagged)
Escherichia coli MagneHis™ system Ni2+ Rapid detection and 
quantitation of 
isolated protein
[85]
Uricase (recombinant, 
histidine-tailed)
Bacillus Ion-chelating magnetic 
agarose beads
Ni2+ Elution by cleavage 
with proteinase K
[92]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
Page 9 of 17
(page number not for citation purposes)
structures, have been used for the isolation of various anti-
gens, both molecules and cells [5] and can thus be used
for the separation of specific proteins.
Magnetic separation procedures can be employed in sev-
eral ways. Preparative isolation of the target protein or
peptide is usually necessary if further detailed study is
intended. In other cases, however, the magnetic separa-
tion can be directly followed (after elution with an appro-
priate buffer) with SDS electrophoresis. Magnetically
separated proteins and peptides can also be used for fur-
ther mass spectroscopy characterization [30,31]. The basic
principles of magnetic separations can be used in the
course of protein or peptide determination using various
types of solid phase immunoassays. Usually immu-
nomagnetic particles directly capture the target analyte, or
magnetic particles with immobilised streptavidin are used
to capture the complex of biotinylated primary antibody
and the analyte. The separated analyte is then determined
(usually without elution) using an appropriate method. A
combination of magnetic separation with affinity capil-
lary electrophoresis is also possible [32].
Enzyme isolation is usually performed using immobilised
inhibitors, cofactors, dyes or other suitable ligands, or
magnetic beads prepared from affinity biopolymers can
be used (see Tables 1, 2, 3, 4).
Genetic engineering enables the construction of gene
fusions resulting in fusion proteins having the combined
properties of the original gene products. To date, a large
number of different gene fusion systems, involving fusion
partners that range in size from one amino acid to whole
proteins, capable of selective interaction with a ligand
immobilized onto magnetic particles or chromatography
matrices, have been described. In such systems, different
types of interactions, such as enzyme-substrate, receptor-
target protein, polyhistidines-metal ion, and antibody-
antigen, have been utilized. The conditions for purifica-
tion differ from system to system and the environment
tolerated by the target protein is an important factor for
deciding which affinity fusion partner to choose. In addi-
tion, other factors, including protein localization, costs
for the affinity matrix and buffers, and the possibilities of
removing the fusion partner by site-specific cleavage,
should also be considered [33,34]. As an example, isola-
tion of recombinant oligohistidine-tagged proteins is
based on the application of metal chelate magnetic
adsorbents [35,36]. This method has been used success-
fully for the purification of proteins expressed in bacterial,
mammalian, and insect systems.
Antibodies from ascites, serum and tissue culture superna-
tants can be efficiently isolated using magnetic particles
with immobilized Protein A, Protein G or anti-immu-
Table 5: Examples of antibodies purified by magnetic techniques
Purified antibody Source Magnetic carrier Affinity ligand Further details Reference
Anti-BODIPY-
fluorescein antibodies
Magnetoliposomes BODIPY-fluorescein [94]
Anti-DNA antibody Systemic lupus 
erythematosus patient 
plasma
Magnetic poly(2-
hydroxyethyl-
methacrylate) beads
DNA Desorption with 1 M 
NaSCN solution
[95]
Anti-human chorionic 
gonadotropin antibody
Murine ascites 
supernatants
Magnetic cellulose beads Human chorionic 
gonadotropin
[96]
Antibody (from rat) Sample from affinity 
chromatography
Dynabeads M-280 Sheep anti-rabbit IgG Antibody concentration [3]
Antibody Rabbit serum Dynabeads M-280 Sheep anti-rabbit IgG Elution with 0.5 M acetic 
acid
[97]
Monoclonal antibodies Mouse hybridoma 
culture broth
Magnetite particles Protein A [98]
Anti-bovine serum 
albumin antibodies
Thermosensitive 
magnetic microspheres
Bovine serum albumin Immobilization by the 
carbodiimide method
[99]
Immunoglobulin G, 
human
Commercial preparation Magnetic poly(ethylene 
glycol dimethacrylate-N-
methacryloly-L-
histidine-methylester) 
beads
Elution with 1 M NaCl [100]
Immunoglobulin G Blood serum Carboxyl-terminated 
magnetic particles
MproteinAG [101]
IgE antibodies Allergic patients sera Magnetoliposomes Antigenic proteins [16]
Murine anti-fibroblast 
growth factor receptor 
1 IgM
Ascites Polystyrene magnetic 
beads
Rat anti-mouse IgM 
monoclonal antibody
[102]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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noglobulin antibodies. Protein A, isolated from Staphylo-
coccus aureus, binds the Fc region of IgG of most
mammalian species with high affinity, leaving antigen
specific sites free. Protein G, isolated from Streptococcus
sp., reacts with a larger number of IgG isotypes. It has a
higher binding affinity to immunoglobulins than Protein
A, however, it also interacts with the Fab regions of IgG,
although the affinity is ten times lower than for the Fc
region [37]. Antiphospholipid antibodies were success-
fully isolated using magnetoliposomes [15].
Aptamers are DNA or RNA molecules that have been
selected from random pools based on their ability to bind
other molecules. Aptamers binding proteins can be
immobilised to magnetic particles and used for isolation
of target proteins.
Table 6: Examples of DNA/RNA/oligonucleotide/aptamer binding proteins purified by magnetic techniques
Purified protein Source Magnetic carrier Affinity ligand Further details Reference
CUG binding proteins Human myoblasts or 
fibroblasts
Dynabeads M-280 
streptavidin
Biotinylated(CUG)10 Elution with 1 M NaCl [103]
Transcription factor τ Saccharomyces cerevisiae Dynabeads M-280 
streptavidin
Biotinylated tRNAGlu 
gene fragment
Elution with high salt 
buffer
[104,105]
DNA-binding proteins Crude tissue extract Magnetic phospho 
cellulose particles
[106]
DNA-binding proteins Escherichia coli Magnetic phospho 
cellulose particles
[107]
DNA-binding proteins HeLa nuclear extracts Dynabeads M-280 
streptavidin
Biotin-labelled DNA 
fragment
Elution with 2 M NaCl [108]
Vaccinia virus early 
transcription factor
Vaccinia virions Dynabeads M-280 
streptavidin
Biotinylated double-
stranded DNA
Elution with high salt 
buffer
[109]
Ecdysteroid receptor Drosophila melanogaster 
nuclear extract
Dynabeads M-280 
streptavidin
Biotinylated double-
stranded oligonucleotide
Elution with 0.4 M KCl [110]
NanR protein 
(recombinant)
Escherichia coli µMACS streptavidin 
MicroBeads
Biotin-labelled DNA 
fragment
Elution with 1 M NaCl [111]
p27 Rabbit hepatocytes Dynabeads M-280 
streptavidin
Guanine-rich single-
stranded DNA
Elution with NaCl 
solution
[112]
Pigpen protein Endothelial cells Magnetic streptavidin 
beads
Biotinylated aptamer Elution with 1 M NaCl [113]
RNA binding proteins Saccharomyces cerevisiae µMACS streptavidin 
MicroBeads
Biotin-labelled RNA 
probe
Elution with 1 M NaCl [114]
Single-stranded 
telomere binding 
protein (sTBP)
Nuclei from vertebrate 
tissues
Dynabeads M-280 
streptavidin
Biotinylated single 
stranded TTAGGGn 
repeats
Elution with high salt 
buffer
[115]
Transcription proteins Human myeloid cells Dynabeads M-280 
streptavidin
Biotinylated serum 
inducible element (hSIE)
Elution with high salt 
buffer
[116]
Transcription factor 
γRF-1
Human monocytes and 
epidermal cells
Dynabeads M-280 
streptavidin
Biotinylated DNA 
containing γRF-1 
sequences
Elution with 0.6 M KCl [117]
Protein factor MS2 Murine skeletal 
myotubes
Dynabeads Double-stranded DNA Elution with 100 mM 
sodium acetate, pH 4.2
[118]
Guide RNA binding 
protein
Trypanosoma brucei 
mitochondria
Dynabeads M-450 goat 
anti-mouse IgG
Monoclonal antibody Elution with low pH 
buffer cont. SDS
[119]
RNA binding proteins Pollen grains Streptavidin 
MagneSphere particles
Biotinylated 
oligonucleotides
Elution with SDS buffer [120]
DNA binding protein Schistosoma mansoni Dynabeads M-280 
streptavidin
Biotinylated DNA Elution with sodium 
acetate buffer
[121]
ssDNA binding proteins Transfected mouse 
fibroblasts
Dynabeads anti-rabbit 
IgG
Rabbit antibody Indirect method [122]
Tenascin-C Glioblastoma cells Dynabeads streptavidin Biotinylated aptamer Elution with high salt 
buffer
[123]
Thermostable brain 
factor (ThBF)
Rat brain Streptavidin magnetic 
particles
Biotinylated 
oligonucleotides
Elution with 0.7 M KCl [124]
TTF1 protein Escherichia coli lysate Dynabeads M-280 
streptavidin
Biotinylated aptamer Elution with DNase [125]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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DNA/RNA binding proteins (e.g., promoters, gene regula-
tory proteins and transcription factors) are often short-
lived and in low abundance. A rapid and sensitive
method, based on the immobilization of biotinylated
DNA/RNA fragments containing the specific binding
sequence to the magnetic streptavidin particles, can be
used. The bound DNA/RNA binding proteins are usually
eluted with high salt buffer or change of pH [38].
Other types of proteins were isolated using specific affin-
ity-based procedures. For example, plasminogen immobi-
lized on magnetic particles was used to separate scrapie
and bovine spongiform encephalopathy associated prion
protein PrPSc from its conformer which is a cellular pro-
tein called PrPC. In fact, plasminogen represents the first
endogenous factor discriminating between normal and
pathological prion protein. This unexpected property may
be exploited for diagnostic purposes [39,40].
Magnetic separation was also successfully used for the
recovery of proteins expressed in the form of inclusion
bodies, involving at first chemical extraction from the
host cells, then adsorptive capture of the target protein
onto small magnetic adsorbents, followed by rapid
collection of the product-loaded supports with the aid of
high gradient magnetic fields [41].
A new approach for analytical ion-exchange separation of
native proteins and proteins enzymatic digest products
has been described recently [31]. Magnetite particles were
covered with a gold layer and then stabilized with ionic
agents. These charged stabilizers present at the surface of
the gold particles are capable of attracting oppositely
charged species from a sample solution through electro-
static interactions. Au@magnetic particles having nega-
tively charged surfaces are suitable probes for selectively
trapping positively charged proteins and peptides from
aqueous solutions. The species trapped by the isolated
particles were then characterized by matrix-assisted laser
desorption/ionization mass spectrometry (MALDI MS)
after a simple washing.
Magnetic solid phase extraction (MSPE) enables to pre-
concentrate target analytes from larger volumes of
solutions or suspensions using relatively small amount of
magnetic specific adsorbent. Up to now this procedure
Table 7: Purification of albumin and haemoglobin by magnetic techniques
Purified protein Source Magnetic carrier Affinity ligand Further details Reference
Albumin, bovine 
serum
Commercial 
preparation
Magnetic agar beads Cibacron blue3GA Adsorption 
experiments
[126]
Commercial 
preparation
Magnetic cross-linked 
polyvinylalcohol
Cibacron blue3GA Adsorption 
experiments
[76,127]
Magnetic chitosan microspheres Cibacron blue3GA [78]
Commercial 
preparation
Magnetic poly(glycidyl 
methacrylate-triallyl 
isocyanurate-divinylbenzene) 
particles
Anion exchange 
separation
[128]
Commercial 
preparation
Magnetic poly(ethylene glycol 
dimethacrylate-co-N-
methacryloyl-(L)-histidine methyl 
ester) microbeads
Cu2+ Elution with 1.0 M 
NaSCN
[129]
Albumin, human 
serum
Commercial 
preparation
Magnetic poly(2-
hydroxyethylmethacrylate) beads
Iminodiacetic acid 
charged with Cu2+
Elution with 1.0 M 
NaSCN
[130]
Human plasma Magnetic poly(2-hydroxyethyl 
methacrylate) beads
Cibacron blue F3GA Elution with 0.5 M 
NaSCN
[131]
Commercial 
preparation
Magnetic particles covered with 
thermosensitive polymer
- Desorption by 
decreasing 
temperature
[132,133]
Albumin, human 
serum (recombinant, 
FLAG tagged)
Yeast cells Magnetic glass beads Anti-FLAG antibody Elution with EDTA 
containing buffer
[1]
Glycated haemoglobin Human blood Magnetic poly(vinyl alcohol) 
beads
m-Aminophenyl-
boronic acid
Elution with sorbitol [138]
Haemoglobin Bovine, commercial 
preparation
Amine terminated iron oxide 
particles
Iminodiacetic acid 
charged with Cu2+
Elution with imidazole 
containing buffer
[63]
Haemoglobin A1c Human blood Magnetic particles isolated from 
Magnetospirillum magneticum 
AMB-1
m-Aminophenyl-
boronic acid
used for affinity 
immunoassay
[150]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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Table 8: Examples of other proteins purified by magnetic techniques
Purified protein Source Magnetic carrier Affinity ligand Further details Reference
Aprotinin Bovine pancreatic 
powder
Magnetic chitosan 
particles
Trypsin Elution with low pH 
buffer
[134]
Concanavalin A Jack bean extract Magnetic particles Dextran [68,135]
Solanum tuberosum lectin Potato tuber Magnetic chitosan Elution with low pH 
buffer
[136]
Green fluorescent 
protein (histidine 
tagged)
Magnetic nanoparticles Ni-NTA Elution with imidazole 
containing buffer
[137]
SIRT2 protein 
(recombinant, histidine 
tailed)
Human Magnetic agarose beads Ni-NTA Elution with imidazole 
containing buffer
[139]
Elongation factor 
(recombinant, histidine 
tailed)
Caenorhabditis elegans Magnetic agarose beads Ni-NTA Elution with imidazole 
containing buffer
[140]
Protein A Recombinant Escherichia 
coli
Magnetic Eudragit Human IgG Magnetic two-phase 
system
[141]
Tumor necrosis factor 
(TNF)
Dynabeads M-280 Mouse monoclonal 
antibody
Solid phase 
immunoassay
[142]
Anti-MUC1 diabody 
fragment
Recombinant Escherichia 
coli
Magnetic agarose beads Specific peptide [143]
MHC class II molecules MDCK cells Dynabeads M-450 rat 
anti-mouse IgG1
Specific antibodies Elution with SDS-PAGE 
buffer
[144]
Lamin B3 Xenopus egg extracts Dynabeads Specific antibodies Elution with 6 M urea [44]
6x-His-tagged proteins Human fibroblasts Magnetic agarose beads Ni-NTA Elution with imidazole 
containing buffer
[145]
Estrogen receptor Adipose tissue Dynabeads M-280 
streptavidin
Biotinylated monoclonal 
mouse anti-human 
estrogen receptor 
antibody
Indirect method [146]
Thiol-reactive 
chromatin restriction 
fragments
Mouse fibroblasts Mercurated agarose 
magnetic beads
p-
Hydroxymercuribenzoat
e
Elution with 0.5 M NaCl 
and 20 mM 
dithiothreitol
[147]
L1 coat protein Human papillomavirus Magnetic 
polyglutaraldehyde 
particles
Iminodiacetic acid 
charged with Cu2+
Elution with imidazole 
containing buffer
[41]
Insulin receptor Rat muscle or liver 
extract
Dynabeads M-450 Anti-P5 antibody SDS PAGE analysis [148]
Stat3 DER cells Dynabeads Biotinylated tyrosine 
phosphorylated peptides
SDS PAGE analysis [149]
Transferrin receptor Human Dynabeads M-450 sheep 
anti-mouse IgG1
Anti-human transferrin 
receptor monoclonal 
antibody
SDS analysis [151]
Prion protein PrPSc Brain extract Dynabeads M-280 tosyl 
activated
Plasminogen SDS analysis [39,40]
Biotinylated proteins 
from extracellular 
matrix
Bipolaris sorokiniana Dynabeads Streptavidin SDS analysis [152]
Cryoprotectin Leaves of cold-
acclimated cabbage 
(Brassica oleracea)
Dynabeads-protein A Specific antibody [153]
Prostate specific antigen Serum from a prostate 
cancer suffering patient
Streptavidin-coated 
magnetic beads
Biotinylated monoclonal 
antibody
Elution with low pH 
solution
[154,155]
Estrogen receptor In vitro translation Magnetic beads Antibody Elution with SDS buffer [156]
VHDL receptor Helicoverpa zea Streptavidin-coated 
magnetic beads
VHDL-biotin ligand [157]
Fructosyllysine-specific 
binding protein
U937 cells Dynabeads M-280 
tosylactivated
Poly-L-lysine-glucose 
conjugate
Two proteins isolated [158]
Ubiquitin (histidine 
tagged)
Nickel-gold nanorods Elution with acidic buffer [18]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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was used for preconcentration of low-molecular weight
xenobiotics [42,43] but using suitable magnetic
adsorbents the MSPE could be used to preconcetrate target
proteins and peptides as well.
Sometimes the removal of certain proteins will reveal
functions involving the depleted proteins or will help in
the course of subsequent protein isolation. As an example,
Dynabeads have been used to remove involved proteins
from Xenopus egg extracts for analyses of the cell mitosis
mechanisms [44,45]. Rapid removal of contaminating
proteolytic enzymes from the crude samples could
increase yields of sensitive proteins due to the limitation
of their proteolysis [46].
A combination of mechanical cell disintegration and mag-
netic batch affinity adsorption was used to simplify the
isolation of intracellular proteins. Magnetic glass beads
were used because of their hardness and rigidity [1].
An example of quite different protein purification strategy
can also be mentioned. Proteins associated with the endo-
cytic vesicles of Dictyostelium discoideum were separated
after magnetic isolation of the vesicles that was accom-
plished by feeding the amoebae with dextran-stabilized
iron oxide particles. The cells were broken, the labelled
vesicles were magnetically separated and then disrupted
to release proteins which were resolved by SDS-PAGE.
After „in-gel“ digestion with endoproteinase Lys-C or Asp-
N the generated peptides were used for amino acid
sequencing. This strategy allowed the identification of the
major protein constituents of the vesicles [47]. Analogous
procedure was used for the separation and study of perox-
isomes proteins when at first peroxisomes were separated
using magnetic beads with immobilized specific antibod-
ies and then the protein content of the separated peroxi-
somes was analysed [48].
Conclusions
Standard liquid column chromatography is currently the
most often used technique for the isolation and purifica-
tion of target proteins and peptides. Magnetic separation
techniques are relatively new and still under develop-
ment. Magnetic affinity particles are currently used mainly
in molecular biology (especially for nucleic acids separa-
tion), cell biology and microbiology (separation of target
cells) and as parts of the procedures for the determination
of selected analytes using magnetic ELISA and related
techniques (especially determination of clinical markers
and environmental contaminants). Up to now
separations in small scale prevail and thus the full poten-
tial of these techniques has not been fully exploited.
It can be expected that further development will be
focused at least on two areas. The first one will be focused
on the laboratory scale application of magnetic affinity
separation techniques in biochemistry and related areas
(rapid isolation of a variety of both low- and high-molec-
ular weight substances of various origin directly from
crude samples thus reducing the number of purification
steps) and in biochemical analysis (application of immu-
nomagnetic particles for separation of target proteins
from the mixture followed by their detection using ELISA
and related principles). Such a type of analysis will enable
to construct portable assay systems enabling e.g. near-
patient analysis of various protein disease markers. New
methodologies, such as the application of chip and
microfluidics technologies, may result in the develop-
ment of magnetic separation processes capable of mag-
netic separation and detection of extremely small amount
of target biologically active compounds [49].
Table 9: Examples of peptides purified by magnetic techniques
Purified peptide Source Magnetic carrier Affinity ligand Further details Reference
Biotinylated peptides Model mixtures Dynabeads M-280 
streptavidin
Streptavidin Used in MALDI-TOF 
mass analysis
[159]
(His)6-Ala-Tyr-Gly Synthetic peptide Dynabeads M-280 
tosylactivated
Aminocaproic 
nitrilotriacetic acid 
charged with Ni2+
Elution with imidazole 
solution
[160]
Synthetic pentapeptides 
against fructose-1,6-
biphosphate aldolase
Synthetic mixture Streptavidin-coated 
magnetic beads
Biotin labelled fructose-
1,6-biphosphate aldolase 
of T. brucei
Pentapeptides were 
anchored on 
polystyrene beads
[161]
Tryptic digest products 
of cytochrome c
Trypsin digested 
cytochrome c
Au@magnetic particles - Ion-exchange separation 
followed by MALDI MS 
analysis
[31]
Glutathione Gold and iron oxide 
nanocomposites
[162]
Nisin Z Lactobacillus lactis EDC activated magnetic 
beads
Anti-nisin antibody Elution with 6 M urea [163]BioMagnetic Research and Technology 2004, 2:7 http://www.biomagres.com/content/2/1/7
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In the second area, larger-scale (industrial) systems are
believed to be developed and used for the isolation of bio-
logically active compounds directly from crude culture
media, wastes from food industry etc., integrating three
classical steps (clarification, concentration and initial
purification) into a single unit operation [50]. It is not
expected that extremely large amounts of low cost prod-
ucts will be isolated using magnetic techniques, but the
attention should be focused onto the isolation of minor,
but highly valuable components present in raw materials.
Of course, prices of magnetic carriers have to be lowered
and special types of low-cost, biotechnology applicable
magnetic carriers and adsorbents prepared by simple and
cheap procedures have to become available. The existence
of inexpensive and effective magnetic separators enabling
large-scale operations is necessary, as well.
In the near future quite new separation strategies can
appear. A novel magnetic separation method, which uti-
lizes the magneto-Archimedes levitation, has been
described recently and applied to separation of biological
materials. By using the feature that the stable levitation
position under a magnetic field depends on the density
and magnetic susceptibility of materials, it was possible to
separate biological materials such as haemoglobin, fibrin-
ogen, cholesterol, and so on. So far, the difference of mag-
netic properties was not utilized for the separation of
biological materials. Magneto-Archimedes separation
may be another way for biological materials separation
[51].
It can be expected that magnetic separations will be used
regularly both in biochemical laboratories and biotech-
nology industry in the near future.
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